| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 2.43e-05 | 2 | 99 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 2.43e-05 | 2 | 99 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.95e-04 | 23 | 99 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.12e-04 | 194 | 99 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 6.33e-04 | 34 | 99 | 3 | GO:0008395 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 4.28e-07 | 4 | 99 | 3 | GO:0002017 | |
| GeneOntologyBiologicalProcess | positive regulation of systemic arterial blood pressure | 9.36e-06 | 28 | 99 | 4 | GO:0003084 | |
| GeneOntologyBiologicalProcess | circulatory system process | C2CD4B AVPR2 CYP11B1 CYP11B2 KCNE5 C2CD4A PPP1R13L TGFB1 SPTBN4 UCN SLC22A3 SCN5A SERPING1 HSD11B2 | 1.05e-05 | 733 | 99 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | blood circulation | C2CD4B AVPR2 CYP11B1 CYP11B2 KCNE5 C2CD4A PPP1R13L TGFB1 SPTBN4 UCN SCN5A SERPING1 HSD11B2 | 1.33e-05 | 648 | 99 | 13 | GO:0008015 |
| GeneOntologyBiologicalProcess | cortisol metabolic process | 2.29e-05 | 12 | 99 | 3 | GO:0034650 | |
| GeneOntologyBiologicalProcess | renal system process | 8.28e-05 | 149 | 99 | 6 | GO:0003014 | |
| GeneOntologyBiologicalProcess | drinking behavior | 8.31e-05 | 18 | 99 | 3 | GO:0042756 | |
| GeneOntologyBiologicalProcess | renal system process involved in regulation of blood volume | 8.31e-05 | 18 | 99 | 3 | GO:0001977 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by hormone | 1.05e-04 | 51 | 99 | 4 | GO:0001990 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability involved in acute inflammatory response | 1.36e-04 | 4 | 99 | 2 | GO:0002528 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 1.55e-04 | 22 | 99 | 3 | GO:1902644 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 1.86e-04 | 59 | 99 | 4 | GO:0045777 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure mediated by a chemical signal | 2.11e-04 | 61 | 99 | 4 | GO:0003044 | |
| HumanPheno | Polydipsia | 2.97e-05 | 53 | 36 | 5 | HP:0001959 | |
| HumanPheno | Poikilocytosis | 6.40e-05 | 62 | 36 | 5 | HP:0004447 | |
| HumanPheno | Decreased circulating renin concentration | 6.83e-05 | 12 | 36 | 3 | HP:0003351 | |
| HumanPheno | Abnormality of the renin-aldosterone axis | 6.83e-05 | 12 | 36 | 3 | HP:0003350 | |
| HumanPheno | Abnormal circulating renin concentration | 7.43e-05 | 33 | 36 | 4 | HP:0040084 | |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 8.04e-05 | 154 | 36 | 7 | HP:0010930 | |
| HumanPheno | Abnormal blood potassium concentration | 1.18e-04 | 113 | 36 | 6 | HP:0011042 | |
| HumanPheno | Secretory adrenocortical adenoma | 1.45e-04 | 3 | 36 | 2 | HP:0011746 | |
| HumanPheno | Episodic fatigue | 1.45e-04 | 3 | 36 | 2 | HP:0012431 | |
| HumanPheno | Hypokalemia | 2.04e-04 | 79 | 36 | 5 | HP:0002900 | |
| HumanPheno | Abnormal drinking behavior | 2.30e-04 | 81 | 36 | 5 | HP:0030082 | |
| HumanPheno | Abnormal urine sodium concentration | 2.46e-04 | 18 | 36 | 3 | HP:0012603 | |
| MousePheno | decreased circulating mineralocorticoid level | 1.46e-06 | 14 | 89 | 4 | MP:0003374 | |
| MousePheno | decreased circulating aldosterone level | 1.46e-06 | 14 | 89 | 4 | MP:0002667 | |
| MousePheno | decreased urine osmolality | 2.31e-05 | 54 | 89 | 5 | MP:0002988 | |
| MousePheno | decreased circulating renin level | 2.90e-05 | 10 | 89 | 3 | MP:0003353 | |
| MousePheno | abnormal urine progesterone level | 4.01e-05 | 2 | 89 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 4.01e-05 | 2 | 89 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 4.01e-05 | 2 | 89 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 4.01e-05 | 2 | 89 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 4.01e-05 | 2 | 89 | 2 | MP:0011546 | |
| MousePheno | cardiac fibrosis | 4.91e-05 | 151 | 89 | 7 | MP:0003141 | |
| MousePheno | abnormal urine osmolality | 5.71e-05 | 65 | 89 | 5 | MP:0002987 | |
| MousePheno | abnormal circulating mineralocorticoid level | 9.60e-05 | 38 | 89 | 4 | MP:0003372 | |
| MousePheno | abnormal circulating aldosterone level | 9.60e-05 | 38 | 89 | 4 | MP:0005346 | |
| MousePheno | abnormal aldosterone level | 1.30e-04 | 41 | 89 | 4 | MP:0011415 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 2.39e-04 | 4 | 89 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 2.39e-04 | 4 | 89 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 2.39e-04 | 4 | 89 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 2.39e-04 | 4 | 89 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 2.39e-04 | 4 | 89 | 2 | MP:0014459 | |
| MousePheno | polyuria | 2.55e-04 | 89 | 89 | 5 | MP:0001762 | |
| MousePheno | increased circulating glucocorticoid level | 3.05e-04 | 51 | 89 | 4 | MP:0003367 | |
| MousePheno | increased circulating corticosterone level | 3.05e-04 | 51 | 89 | 4 | MP:0001745 | |
| MousePheno | abnormal urination | 3.59e-04 | 148 | 89 | 6 | MP:0001756 | |
| MousePheno | decreased circulating potassium level | 3.81e-04 | 54 | 89 | 4 | MP:0005628 | |
| MousePheno | increased adrenal gland zona fasciculata size | 3.96e-04 | 5 | 89 | 2 | MP:0014286 | |
| MousePheno | increased circulating renin level | 4.03e-04 | 23 | 89 | 3 | MP:0003352 | |
| MousePheno | oliguria | 4.58e-04 | 24 | 89 | 3 | MP:0003620 | |
| MousePheno | ventricular tachycardia | 4.58e-04 | 24 | 89 | 3 | MP:0008950 | |
| MousePheno | ventricular premature beat | 5.18e-04 | 25 | 89 | 3 | MP:0009732 | |
| MousePheno | abnormal cyst | 5.62e-04 | 294 | 89 | 8 | MP:0031310 | |
| MousePheno | uterus adenomyosis | 5.91e-04 | 6 | 89 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 5.91e-04 | 6 | 89 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 5.91e-04 | 6 | 89 | 2 | MP:0009078 | |
| MousePheno | abnormal urine homeostasis | ZNF219 AVPR2 CYP11B1 CYP11B2 SLC4A1 TGFB1 PXMP2 PRKDC HSD11B2 HPS5 | 7.41e-04 | 466 | 89 | 10 | MP:0009643 |
| MousePheno | abnormal circulating renin level | 8.09e-04 | 29 | 89 | 3 | MP:0003349 | |
| MousePheno | abnormal urine hormone level | 8.24e-04 | 7 | 89 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 8.24e-04 | 7 | 89 | 2 | MP:0000635 | |
| MousePheno | dilated distal convoluted tubule | 8.24e-04 | 7 | 89 | 2 | MP:0009051 | |
| MousePheno | abnormal lymph node size | KATNAL2 NOL3 SLC35C1 PRAMEF19 PRAMEF18 CCDC88B TGFB1 ULK3 STOML1 PRKDC TEDC1 | 8.43e-04 | 561 | 89 | 11 | MP:0000701 |
| MousePheno | abnormal chloride level | 8.44e-04 | 174 | 89 | 6 | MP:0012007 | |
| Domain | - | PRAMEF19 PIDD1 NLRP1 LRRC4C PRAMEF18 LRRC43 CIITA LINGO4 LRRC28 LRRC23 | 8.62e-06 | 321 | 100 | 10 | 3.80.10.10 |
| Domain | L_dom-like | PRAMEF19 PIDD1 NLRP1 LRRC4C PRAMEF18 LRRC43 CIITA LINGO4 LRRC28 LRRC23 | 1.04e-05 | 328 | 100 | 10 | IPR032675 |
| Domain | Cyt_P450_mitochondrial | 2.84e-05 | 2 | 100 | 2 | IPR002399 | |
| Domain | LRR | 1.04e-04 | 201 | 100 | 7 | PS51450 | |
| Domain | Leu-rich_rpt | 1.04e-04 | 271 | 100 | 8 | IPR001611 | |
| Domain | LRR_1 | 1.76e-04 | 219 | 100 | 7 | PF00560 | |
| Domain | Pentatricopeptide_repeat | 2.44e-04 | 23 | 100 | 3 | IPR002885 | |
| Domain | ARM-type_fold | 4.74e-04 | 339 | 100 | 8 | IPR016024 | |
| Domain | AAA+_ATPase | 1.06e-03 | 144 | 100 | 5 | IPR003593 | |
| Domain | AAA | 1.06e-03 | 144 | 100 | 5 | SM00382 | |
| Domain | - | 1.24e-03 | 222 | 100 | 6 | 1.25.10.10 | |
| Domain | JmjN | 1.24e-03 | 10 | 100 | 2 | SM00545 | |
| Domain | JMJN | 1.24e-03 | 10 | 100 | 2 | PS51183 | |
| Domain | MKP | 1.24e-03 | 10 | 100 | 2 | IPR008343 | |
| Domain | JmjN | 1.24e-03 | 10 | 100 | 2 | PF02375 | |
| Domain | JmjN | 1.24e-03 | 10 | 100 | 2 | IPR003349 | |
| Domain | - | 1.57e-03 | 93 | 100 | 4 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.97e-03 | 99 | 100 | 4 | IPR011029 | |
| Domain | LRR_8 | 2.27e-03 | 171 | 100 | 5 | PF13855 | |
| Domain | ATPase_AAA_core | 3.03e-03 | 54 | 100 | 3 | IPR003959 | |
| Domain | LRR_6 | 3.19e-03 | 55 | 100 | 3 | PF13516 | |
| Domain | ARM-like | 3.31e-03 | 270 | 100 | 6 | IPR011989 | |
| Domain | CYTOCHROME_P450 | 3.53e-03 | 57 | 100 | 3 | PS00086 | |
| Domain | - | 3.71e-03 | 58 | 100 | 3 | 1.10.630.10 | |
| Domain | p450 | 3.71e-03 | 58 | 100 | 3 | PF00067 | |
| Domain | Cyt_P450 | 4.09e-03 | 60 | 100 | 3 | IPR001128 | |
| Domain | PRAME_family | 4.57e-03 | 19 | 100 | 2 | IPR026271 | |
| Domain | RHOD | 6.11e-03 | 22 | 100 | 2 | SM00450 | |
| Domain | HEAT_REPEAT | 6.29e-03 | 70 | 100 | 3 | PS50077 | |
| Domain | NACHT | 6.67e-03 | 23 | 100 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 6.67e-03 | 23 | 100 | 2 | IPR007111 | |
| Domain | RHODANESE_3 | 6.67e-03 | 23 | 100 | 2 | PS50206 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 1.11e-06 | 5 | 69 | 3 | M47522 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.31e-05 | 10 | 69 | 3 | M27076 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.80e-05 | 11 | 69 | 3 | MM14750 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 3.93e-05 | 14 | 69 | 3 | M46449 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 3.93e-05 | 14 | 69 | 3 | M46453 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 6.00e-05 | 16 | 69 | 3 | M39815 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 2.39e-04 | 25 | 69 | 3 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 3.02e-04 | 27 | 69 | 3 | MM14844 | |
| Pubmed | Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. | 1.32e-06 | 8 | 101 | 3 | 27798095 | |
| Pubmed | 2.82e-06 | 210 | 101 | 7 | 16565220 | ||
| Pubmed | 3.86e-06 | 11 | 101 | 3 | 19270065 | ||
| Pubmed | Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. | 3.86e-06 | 11 | 101 | 3 | 20486282 | |
| Pubmed | 5.13e-06 | 12 | 101 | 3 | 22919064 | ||
| Pubmed | 6.66e-06 | 13 | 101 | 3 | 24580729 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23150505 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 8.35e-06 | 2 | 101 | 2 | 21164264 | |
| Pubmed | MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. | 8.35e-06 | 2 | 101 | 2 | 16081800 | |
| Pubmed | Maid is a negative regulator of transforming growth factor-β-induced cell migration. | 8.35e-06 | 2 | 101 | 2 | 26002959 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 8645611 | ||
| Pubmed | Delayed wound healing in immunodeficient TGF-beta 1 knockout mice. | 8.35e-06 | 2 | 101 | 2 | 10886500 | |
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 8.35e-06 | 2 | 101 | 2 | 12231255 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20634641 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 1303253 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 1741400 | ||
| Pubmed | Host-derived TGFB1 deficiency suppresses lesion development in a mouse model of endometriosis. | 8.35e-06 | 2 | 101 | 2 | 22210480 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 32540969 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26047574 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26324851 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 7669222 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22933298 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 8.35e-06 | 2 | 101 | 2 | 2256920 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 8.35e-06 | 2 | 101 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 8.35e-06 | 2 | 101 | 2 | 16396990 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 8.35e-06 | 2 | 101 | 2 | 18397978 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 1518866 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23290315 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 8.35e-06 | 2 | 101 | 2 | 2592361 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 23314847 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 8.35e-06 | 2 | 101 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 8.35e-06 | 2 | 101 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 8.35e-06 | 2 | 101 | 2 | 15731365 | |
| Pubmed | Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease. | 8.35e-06 | 2 | 101 | 2 | 28630289 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16269452 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17651452 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 34743356 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 8.35e-06 | 2 | 101 | 2 | 20339375 | |
| Pubmed | Monogenic Hypertension in Children: A Review With Emphasis on Genetics. | 8.35e-06 | 2 | 101 | 2 | 29229168 | |
| Pubmed | C2CD4A/B variants in the predisposition of lung cancer in the Chinese Han population. | 8.35e-06 | 2 | 101 | 2 | 35212842 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 33492421 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18614704 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 20808686 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 8.35e-06 | 2 | 101 | 2 | 21519965 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 29625024 | ||
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 8.35e-06 | 2 | 101 | 2 | 21625068 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 16110193 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 26066897 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18651133 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22083159 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 8.35e-06 | 2 | 101 | 2 | 15699546 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 18162527 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 38341019 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 24837548 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 8.35e-06 | 2 | 101 | 2 | 19820005 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 8.35e-06 | 2 | 101 | 2 | 15062555 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17075030 | ||
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 17075029 | ||
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 8.35e-06 | 2 | 101 | 2 | 15507509 | |
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 8.35e-06 | 2 | 101 | 2 | 17296872 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 8.35e-06 | 2 | 101 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 8.35e-06 | 2 | 101 | 2 | 19029289 | |
| Pubmed | 8.35e-06 | 2 | 101 | 2 | 15522937 | ||
| Pubmed | 1.30e-05 | 16 | 101 | 3 | 37727456 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYBBP1A CAND2 PSMC3 GALNT12 HSPBP1 FANCA THEM6 UBR5 CEBPZ PXMP2 LRP6 PRKDC | 1.90e-05 | 942 | 101 | 12 | 31073040 |
| Pubmed | Genome-wide association study identifies three novel loci for type 2 diabetes. | 2.23e-05 | 19 | 101 | 3 | 23945395 | |
| Pubmed | 2.48e-05 | 197 | 101 | 6 | 31620119 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 2546938 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 16118390 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 17984374 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 2233742 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 33271253 | ||
| Pubmed | The prolactin regulatory element-binding regulates of the 11beta-hydroxylase gene. | 2.50e-05 | 3 | 101 | 2 | 18801336 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 11932209 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21347312 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21467193 | ||
| Pubmed | The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator. | 2.50e-05 | 3 | 101 | 2 | 19853614 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 7750493 | ||
| Pubmed | Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone Synthesis. | 2.50e-05 | 3 | 101 | 2 | 26471128 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 19948884 | ||
| Pubmed | A novel gene family induced by acute inflammation in endothelial cells. | 2.50e-05 | 3 | 101 | 2 | 15527968 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 28355486 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 36861295 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 20818381 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 36778748 | ||
| Pubmed | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 2.50e-05 | 3 | 101 | 2 | 8111631 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 21799836 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 31819138 | ||
| Pubmed | Interaction of CYP11B1 (cytochrome P-45011 beta) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. | 2.50e-05 | 3 | 101 | 2 | 10411633 | |
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 18974272 | ||
| Pubmed | 2.50e-05 | 3 | 101 | 2 | 27329800 | ||
| Pubmed | Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. | 2.50e-05 | 3 | 101 | 2 | 1686470 | |
| Pubmed | Mislocalization of protein kinase A drives pathology in Cushing's syndrome. | 2.50e-05 | 3 | 101 | 2 | 35830806 | |
| GeneFamily | Cytochrome P450 family 11 | 4.17e-05 | 3 | 68 | 2 | 1007 | |
| GeneFamily | AAA ATPases | 4.66e-05 | 53 | 68 | 4 | 413 | |
| GeneFamily | MAP kinase phosphatases | 7.50e-04 | 11 | 68 | 2 | 895 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.65e-03 | 24 | 68 | 2 | 485 | |
| GeneFamily | PRAME family | 3.65e-03 | 24 | 68 | 2 | 686 | |
| GeneFamily | NLR family | 3.95e-03 | 25 | 68 | 2 | 666 | |
| Coexpression | HAY_BONE_MARROW_ERYTHROBLAST | TROAP PSMC3 MCM7 XK HSPBP1 SLC4A1 FANCA PKMYT1 THEM6 GRPEL1 MDN1 MRPL15 CLPB IFRD2 FBXO7 FADS2 PRKDC | 5.97e-06 | 1271 | 100 | 17 | M39197 |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 1.03e-05 | 129 | 100 | 6 | M41687 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN | 1.19e-05 | 200 | 100 | 7 | M4300 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN | 3.75e-05 | 162 | 100 | 6 | M8995 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.44e-06 | 62 | 97 | 5 | gudmap_developingKidney_e12.5_renal vesicle_1000_k2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-06 | 180 | 101 | 6 | 1c1b25f1d22518db5469707131510daae84716a3 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 182 | 101 | 6 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-05 | 140 | 101 | 5 | ab90f6f30d89761687f8836e3d327d143ce49ed4 | |
| ToppCell | Healthy_donor-RBC|World / disease group, cell group and cell class (v2) | 2.36e-05 | 150 | 101 | 5 | 1e1a497ec4b048f7e9cc12dd5dd9aba7fedca9e1 | |
| ToppCell | Healthy_donor-RBC|Healthy_donor / disease group, cell group and cell class (v2) | 2.68e-05 | 154 | 101 | 5 | e080d5104fe6f3f6ef617bbcdccf1332ab7231e1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-05 | 157 | 101 | 5 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-05 | 157 | 101 | 5 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.93e-05 | 157 | 101 | 5 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 158 | 101 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 160 | 101 | 5 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 162 | 101 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 169 | 101 | 5 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-05 | 169 | 101 | 5 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | facs-Heart-LV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-05 | 170 | 101 | 5 | 2491f3849e34b0ccd06015fa59d15e3d7963c76d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 172 | 101 | 5 | acdc261001f63a8cfce1216ef1e33b4e034b1c11 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 172 | 101 | 5 | 8ccc3459dbdf103c631aa2a0defb8790c06ad6c1 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 173 | 101 | 5 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 173 | 101 | 5 | 97391a763c17ce0107c9e2386e88c417ac75a72e | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 89 | 101 | 4 | 56039e126e6f3e8fcaf3c47237c980e514512536 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 178 | 101 | 5 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 178 | 101 | 5 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 178 | 101 | 5 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.48e-05 | 179 | 101 | 5 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.63e-05 | 180 | 101 | 5 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 180 | 101 | 5 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-05 | 181 | 101 | 5 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.25e-05 | 184 | 101 | 5 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | COVID-cycling-|COVID / Condition, Cell_class and T cell subcluster | 6.41e-05 | 185 | 101 | 5 | eb74b8d36f7b749e04bc2ed4b36f7e1ac7bb6d5f | |
| ToppCell | COVID-cycling|COVID / Condition, Cell_class and T cell subcluster | 6.41e-05 | 185 | 101 | 5 | 5112f966735fa48f0606adcfd5c0212ad5d3d77a | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.06e-05 | 97 | 101 | 4 | 1da964954a95c497ac4a24df1ea3575df5747025 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.06e-05 | 97 | 101 | 4 | dd188763ba02337e4f25d56766eda886cffa810d | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.06e-05 | 97 | 101 | 4 | a0242258aad0766450ff52fe28278cbb2b8d63a0 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.C1ql3_(Hippocampus_Excitatory_Neuron)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.06e-05 | 97 | 101 | 4 | 98a31b9bf0adcad1cb1d803bf7a23d49b4e1f2d5 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 7.27e-05 | 190 | 101 | 5 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 190 | 101 | 5 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 7.45e-05 | 191 | 101 | 5 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.64e-05 | 192 | 101 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x5'-bone_marrow|World / Manually curated celltypes from each tissue | 7.64e-05 | 192 | 101 | 5 | 34777fa7dc001b6d601376a23aab995e2cec043c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.82e-05 | 193 | 101 | 5 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.82e-05 | 193 | 101 | 5 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 100 | 101 | 4 | ea36e4ff513d66186b92e39c549e55c26609cb30 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-05 | 100 | 101 | 4 | ceca7d9342e5ee7293f07edb815beee4eb010fe7 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 194 | 101 | 5 | c9ebdcc2ea600975dade68a41fa65d1f8a5a5926 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.21e-05 | 195 | 101 | 5 | be8db0a22ef8ce24819f790b0bd93670e73af76f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.21e-05 | 195 | 101 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | (4)_B_Hypermutation|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.21e-05 | 195 | 101 | 5 | 54d2acaff6be6b5604591bdbd7d769ac3e74f223 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.41e-05 | 196 | 101 | 5 | e994aa72b362a4f4930b94505a99c0a87e9b163c | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 8.62e-05 | 197 | 101 | 5 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.62e-05 | 197 | 101 | 5 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | COVID-19-COVID-19_Mild-Others-RBC|COVID-19_Mild / Disease, condition lineage and cell class | 8.62e-05 | 197 | 101 | 5 | 3bae601e5d9689ea57e923814af8cdcae690becc | |
| ToppCell | 21-Trachea-RBC|Trachea / Age, Tissue, Lineage and Cell class | 8.62e-05 | 197 | 101 | 5 | 9f8eb6305ade0654bbcd8f19963be0b64af083de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-05 | 197 | 101 | 5 | 17bd2aef8d8792703973643ec9743efd546b7b69 | |
| ToppCell | 21-Trachea-RBC-RBC|Trachea / Age, Tissue, Lineage and Cell class | 8.62e-05 | 197 | 101 | 5 | 4710b55806a618076a954190f519e49c55d300d3 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.83e-05 | 198 | 101 | 5 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-05 | 198 | 101 | 5 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 8.83e-05 | 198 | 101 | 5 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.83e-05 | 198 | 101 | 5 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.83e-05 | 198 | 101 | 5 | 8be58e41ae7870d268e7ce5ab937769e2ecb60d9 | |
| ToppCell | MS-Multiple_Sclerosis-Others-RBC|Multiple_Sclerosis / Disease, condition lineage and cell class | 9.04e-05 | 199 | 101 | 5 | b9e7549f67bc33284bacf9a160b3916651659809 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.04e-05 | 199 | 101 | 5 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 9.25e-05 | 200 | 101 | 5 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | severe-T/NK_proliferative|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c | |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 1da366e35a05f73253629663eeea1fed4ebd7b52 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-05 | 200 | 101 | 5 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | severe-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | d341f4e500377a5bef82c24bf64704b981053336 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.25e-05 | 200 | 101 | 5 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.28e-04 | 113 | 101 | 4 | dc002185095590fc071b2f39259f8b87a757e174 | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 1.46e-04 | 117 | 101 | 4 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.61e-04 | 120 | 101 | 4 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.25e-04 | 131 | 101 | 4 | 537a79ea2b5d6b3dc0444570b1acbceda59b0d7c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-04 | 134 | 101 | 4 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-04 | 138 | 101 | 4 | 6b83c434895d82eaf3c222eef27acec76f9c0a77 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.75e-04 | 138 | 101 | 4 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefm_(MGE-derived_cortical_interneurons--basket_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 56 | 101 | 3 | ac776a6e8d0b5596dc492a05235e518cbfc7b5ed | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefm_(MGE-derived_cortical_interneurons--basket_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.79e-04 | 56 | 101 | 3 | 0417516b9241a756fb2bcd611691c675ca98030d | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 56 | 101 | 3 | 64bb7d3632b14452b6b861f73880b1dab729a0cf | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.82e-04 | 139 | 101 | 4 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.23e-04 | 144 | 101 | 4 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.40e-04 | 146 | 101 | 4 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.40e-04 | 146 | 101 | 4 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 152 | 101 | 4 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.96e-04 | 152 | 101 | 4 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-myeloid_DC_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.96e-04 | 152 | 101 | 4 | bffbbdf1047c59e5241c99dc10b36cfe2071aa48 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.06e-04 | 153 | 101 | 4 | 859de35b24c5d7d73be1c213b90b43362ee2e0eb | |
| ToppCell | Ciliated_cells-A-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.16e-04 | 154 | 101 | 4 | 3b938e23324f7edb56797b4a76fb96ff588142cf | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-04 | 156 | 101 | 4 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.37e-04 | 156 | 101 | 4 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 157 | 101 | 4 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.48e-04 | 157 | 101 | 4 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.70e-04 | 159 | 101 | 4 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 159 | 101 | 4 | cdbccb83af6220bab300dfe56443ff69f6e2043a | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 4.81e-04 | 160 | 101 | 4 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.81e-04 | 160 | 101 | 4 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| Drug | 11 alpha-hydroxyprogesterone | 1.61e-06 | 20 | 100 | 4 | CID000092730 | |
| Disease | P wave duration | 1.40e-07 | 15 | 96 | 4 | EFO_0005094 | |
| Disease | Glucocorticoid-remediable aldosteronism | 1.05e-05 | 2 | 96 | 2 | C1260386 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 1.05e-05 | 2 | 96 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Xerocytosis | 3.14e-05 | 3 | 96 | 2 | C0272051 | |
| Disease | renal tubular acidosis (biomarker_via_orthology) | 3.14e-05 | 3 | 96 | 2 | DOID:14219 (biomarker_via_orthology) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 3.14e-05 | 3 | 96 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | Paroxysmal familial ventricular fibrillation | 6.26e-05 | 4 | 96 | 2 | C0340493 | |
| Disease | hypertension (implicated_via_orthology) | 6.33e-05 | 128 | 96 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 1.04e-04 | 5 | 96 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Conn Syndrome | 1.56e-04 | 6 | 96 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 1.56e-04 | 6 | 96 | 2 | C0020428 | |
| Disease | protocadherin alpha-7 measurement | 2.18e-04 | 7 | 96 | 2 | EFO_0801973 | |
| Disease | skeletal age | 2.18e-04 | 7 | 96 | 2 | EFO_0020898 | |
| Disease | Hematological Disease | 2.90e-04 | 8 | 96 | 2 | C0018939 | |
| Disease | premature birth, parental genotype effect measurement | 3.72e-04 | 9 | 96 | 2 | EFO_0003917, EFO_0005939 | |
| Disease | protein FAM163B measurement | 3.72e-04 | 9 | 96 | 2 | EFO_0802936 | |
| Disease | familial hyperlipidemia | 4.05e-04 | 106 | 96 | 4 | MONDO_0001336 | |
| Disease | androstenedione measurement | 4.63e-04 | 10 | 96 | 2 | EFO_0007972 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0021862 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 7.92e-04 | 221 | 96 | 5 | C0011860 | |
| Disease | breast cancer (is_implicated_in) | 1.48e-03 | 150 | 96 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | triglyceride measurement, body fat percentage | 2.11e-03 | 21 | 96 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.32e-03 | 22 | 96 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | BMI-adjusted fasting blood glucose measurement | 2.53e-03 | 23 | 96 | 2 | EFO_0008036 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.53e-03 | 23 | 96 | 2 | OBA_2045181 | |
| Disease | monocyte percentage of leukocytes | 2.67e-03 | 731 | 96 | 8 | EFO_0007989 | |
| Disease | Brugada Syndrome (disorder) | 2.76e-03 | 24 | 96 | 2 | C1142166 | |
| Disease | diacylglycerol 34:2 measurement | 2.99e-03 | 25 | 96 | 2 | EFO_0010353 | |
| Disease | apolipoprotein L1 measurement | 2.99e-03 | 25 | 96 | 2 | EFO_0021854 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.24e-03 | 26 | 96 | 2 | DOID:234 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VLLALRELLNLRDPA | 646 | Q86VI1 | |
| RTSLLLLRLNDAALR | 21 | Q9HB65 | |
| RLAELLLEREPLCLR | 226 | A6NC98 | |
| RPQDREELLRALLLK | 146 | P02730 | |
| QDRALTLLRDRPLLL | 591 | P33076 | |
| ETLLRLLLRIVDRAP | 21 | P0C7U1 | |
| LLTALLRLFLSRPAE | 476 | Q9Y6B7 | |
| LLLIESRLEPVRFLR | 111 | Q14406 | |
| LQELEALLLRSRDPR | 101 | A6QL63 | |
| DLRDLLLFLAERLPT | 96 | O60826 | |
| AARALLQLLRSDLRL | 16 | P80365 | |
| RLLEKQLSEPDRRLL | 151 | Q6ZUS5 | |
| FLLALVRRELKSRPL | 176 | Q8N0U7 | |
| RLSRLLLRLPALRLM | 546 | P13056 | |
| LLLLLPSLRFITAER | 371 | Q9Y5X4 | |
| RKLLDDEQPLRLRLL | 261 | Q9NS23 | |
| LERSEMLLLLLRRFP | 126 | Q9NVR2 | |
| TVRLLRLLRLLPRLD | 336 | Q9ULD8 | |
| EKPLLRALLDIIRSL | 416 | O95864 | |
| VGRQLRPLLLDLLER | 61 | Q9NU22 | |
| NRLREPLLRRLSELL | 31 | Q9UDY8 | |
| VRLARRSLPALALSL | 6 | Q9HAV7 | |
| LELTRLLPLRFVRIS | 116 | Q8IYT1 | |
| SQRLRTLLSRLLLEL | 6 | Q9UJ90 | |
| LDPLLSALRLDSSRL | 21 | Q9UPZ3 | |
| LLRVPDGLLSRALRA | 176 | A6NLJ0 | |
| TLLRDPREAERTLLL | 16 | Q05923 | |
| VLACLLPDRALRTRL | 66 | Q05923 | |
| LRDLPKLRALVLLDN | 266 | Q53EV4 | |
| LARALLRARLDPAAL | 136 | Q9UHG2 | |
| LRRLEKRILVDLPSR | 411 | Q8IYT4 | |
| LDRPEKLLLLQDIRS | 601 | Q9H5P4 | |
| TLRRPRCLLETLRLA | 831 | Q9C000 | |
| ALRFIRLEPLRALLE | 331 | Q5VWM3 | |
| ALSVALPALLLRRLR | 41 | Q99956 | |
| DIVLRRAALGLRLLP | 361 | B2RXH2 | |
| LLLARRTDLRRISLD | 331 | O75581 | |
| LPALADDILQLSRRR | 546 | Q7L4E1 | |
| RFLRALRLLELPQIL | 196 | A8MYU2 | |
| IPSLRRLDLGELKRL | 171 | Q9HCJ2 | |
| LEAVLLALARIRRAL | 1891 | O95613 | |
| DRKLPAIALDLLRLA | 261 | Q9BQG0 | |
| LELLEPLLSIIRRSL | 846 | Q9BQG0 | |
| LLAILRLSTALARLR | 606 | P33993 | |
| SLRLDLRVARSVLPL | 106 | Q96A29 | |
| LERRSLLSILPVLAL | 281 | Q9GZZ7 | |
| LRHLAEELRLLLPRV | 21 | O95273 | |
| PLELKLRIFRLLDVR | 336 | Q9Y3I1 | |
| SDLRLGRLLLRVAPD | 1311 | O15360 | |
| ELPLLRAALKETLRL | 361 | P15538 | |
| PTLLAELRLLRQRKD | 476 | O60941 | |
| PRELRRGREALLVLL | 11 | Q8IXK2 | |
| RLLDSLPSDTRLVLL | 276 | P05155 | |
| ALASRLLPDFLLERR | 166 | Q12894 | |
| LLPDFLLERRLTLAD | 171 | Q12894 | |
| LLDTLADQLPRLLAR | 136 | Q8N539 | |
| ALAPRLLLRLLRSPT | 11 | Q9H078 | |
| ELPLLRAALKETLRL | 361 | P19099 | |
| GLLEARARTPRLLLL | 6 | Q6PCB8 | |
| DRINRSLEELRLLLL | 26 | Q9BYE0 | |
| EPTLLLLLDRLRNEI | 611 | O75155 | |
| LLLDRLRNEITRLPA | 616 | O75155 | |
| LILLTIERLGRRLPF | 396 | O75751 | |
| RRARLNPLVLLLDAA | 621 | Q8WUF5 | |
| LLRVPDGLLSRALRA | 181 | Q8NCU7 | |
| ELLITDLLPDNRKLR | 291 | Q03701 | |
| ETLRLRAAPTLLRLV | 346 | Q9UNU6 | |
| SRLLSARPGLRLLAL | 6 | P12532 | |
| AEELAKLRLRIDPRL | 431 | Q8N309 | |
| ARLPALVALRLRELD | 201 | Q6UY18 | |
| LVALRLRELDIGRLP | 206 | Q6UY18 | |
| RLPLLTRLDLRDNQL | 261 | Q9HB75 | |
| RLLLILRDPSERVLS | 141 | O14792 | |
| LGALRKLLRLLDRDA | 186 | Q9NZL4 | |
| LARFEQLISRRPLLL | 331 | Q9HCS7 | |
| RALDLLRGLPRVSLA | 11 | Q9P015 | |
| LRLLEPFEVRTRLLG | 111 | Q8WUY1 | |
| RLAFLPLDLGRSREL | 191 | Q86X40 | |
| RLRSPALARRLLLAV | 131 | Q9NPC1 | |
| ALLRRRALQLEELTL | 1071 | Q7Z494 | |
| TLRFIRLEPLRALLE | 331 | Q5SWL8 | |
| LLAILPEAARARRIR | 156 | P57086 | |
| ISRPCALALLRRDVL | 301 | Q6ZV89 | |
| SLRTLRALRPLRALS | 1301 | Q14524 | |
| LRRAAPLTAIALLVL | 6 | Q96DD7 | |
| LPDAERRVRRLLLLV | 51 | O60936 | |
| LLREALERRLGELPA | 266 | Q16512 | |
| LLELRDISGRLLREV | 101 | Q9BWV2 | |
| RERLAALTLLPESRI | 116 | Q9H2W2 | |
| EVPLAGLRRLLLDRL | 101 | Q9NR77 | |
| GLRRLLLDRLVFAPA | 106 | Q9NR77 | |
| LRATAEALLALPVLR | 346 | Q99640 | |
| EADLRALLCRELRPL | 356 | Q9UBI4 | |
| DILDPALLRSGRLDR | 336 | P17980 | |
| EPVLLSRAELRLLRL | 146 | P01137 | |
| LLSPFRALLRTLERE | 291 | Q86SX3 | |
| LSNLAPRTLALRERL | 701 | Q12815 | |
| LEPLQERRRLLLASK | 1501 | Q9H254 | |
| LSLLLRDDRVLPLRA | 1171 | Q14997 | |
| RLLEEALLRLLPAEL | 2891 | P78527 | |
| SELLLDRRLRIPELE | 1646 | Q92508 | |
| ARALLLLLAERFPRR | 51 | P55089 | |
| DLSRDRPLVLLLHLL | 61 | P51811 | |
| AARLLLELEERALLR | 116 | Q9P2Y4 | |
| TRDPLLARAELALLS | 31 | P30518 | |
| VLLLPLERDSELLRE | 296 | O95071 | |
| RPLLSRDCRDLLQRL | 236 | Q6PHR2 | |
| RRPRLETILALLVAL | 1251 | P41229 |